Literature DB >> 30651244

How I treat… alcohol-related liver disease.

Luke D Tyson1, Heather Lewis2.   

Abstract

Age-standardised mortality from liver disease in the United Kingdom has risen by 400% since 1970, with three-quarters of deaths from alcohol-related liver disease (ARLD). The 2013 National Confidential Enquiry into Patient Outcome and Death report found that only 47% of the patients dying in hospital from liver disease experienced 'good' care. We discuss common complications in the care of patients with ARLD and the evidence-based best practice that can improve patient outcomes, with a focus on the initial management of patients presenting acutely to the medical take. © Royal College of Physicians 2019. All rights reserved.

Entities:  

Keywords:  Alcohol; best practice; cirrhosis; decompensation; withdrawal; ­dependence

Year:  2019        PMID： 30651244      PMCID： PMC6399631          DOI： 10.7861/clinmedicine.19-1-43

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  25 in total

1.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

Review 2.  Acamprosate for alcohol dependence.

Authors:  Susanne Rösner; Andrea Hackl-Herrwerth; Stefan Leucht; Philippe Lehert; Simona Vecchi; Michael Soyka
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 3.  The alcohol withdrawal syndrome.

Authors:  A McKeon; M A Frye; Norman Delanty
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11-06       Impact factor: 10.154

Review 4.  Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis.

Authors:  Annette D Fialla; Mads Israelsen; Ole Hamberg; Aleksander Krag; Lise Lotte Gluud
Journal:  Liver Int       Date:  2015-02-15       Impact factor: 5.828

Review 5.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

6.  Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial.

Authors:  Mike J Crawford; Robert Patton; Robin Touquet; Colin Drummond; Sarah Byford; Barbara Barrett; Ben Reece; Adrian Brown; John A Henry
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

7.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Luisa Vonghia; Antonio Mirijello; Ludovico Abenavoli; Cristina D'Angelo; Fabio Caputo; Antonella Zambon; Paul S Haber; Giovanni Gasbarrini
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

8.  Fatal fulminant hepatic failure related to the use of disulfiram.

Authors:  Thomas E Watts; Richa A Pandey; Tobias J Vancil
Journal:  J Ark Med Soc       Date:  2014-06

9.  Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.

Authors:  Yaseen M Arabi; Saqib I Dara; Ziad Memish; Abdulmajeed Al Abdulkareem; Hani M Tamim; Nehad Al-Shirawi; Joseph E Parrillo; Peter Dodek; Stephen Lapinsky; Daniel Feinstein; Gordon Wood; Sandra Dial; Sergio Zanotti; Anand Kumar
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 10.  Transplanting Patients with Alcohol-related Liver Disease in the National Health System: New Rules and Decisions.

Authors:  Richard Parker; Andrew Holt
Journal:  Alcohol Alcohol       Date:  2018-03-01       Impact factor: 2.826
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.